Diagnosed with Mesothelioma? Call 877-MESOTHELIOMA or Live Chat now for a Free Legal Compensation Consultation

Research Articles: Page 1 of 15

There’s some good news for patients with pleural mesothelioma that are eligible for extrapleural pneumonectomy surgery.  On January 21st, The Lancet published a study sharing the results of the SMART (Surgery for Mesothelioma After Radiation Therapy) protocol which can improve the life expectancy of pleural mesothelioma patients by up to five-and-a-half years.  Between 2008 and 2019, 96 patients were tested with the SMART protocol. The SMART protocol involves exposing the patient to [...]

Continue reading

Happy New Year! As 2021 begins, there are many promising things to look forward to in the mesothelioma community and in the world.  As COVID-19 defined 2020 and introduced us all to social distancing, quarantining, PPE, and face masks. Hopefully 2021 will be defined by vaccinations and a return to our new normal.  Lessons have been learned and lives have been changed. As we reflect on the year 2020 in the mesothelioma community, there was some progress made in various aspects of treatment [...]

Continue reading

Given that mesothelioma is such an aggressive cancer, it is always exciting when new treatments are discovered. CAR-T cell immunotherapy is a newer approach to cancer treatment that works to modify a patient’s white blood cells in hopes that they will attack and destroy cancer cells. When a T cell finds the antigens of a cancer cell, it triggers the entire immune system to fight back. By capturing a patient’s T cells and altering them to seek out a specific cancer cell and reintroducing [...]

Continue reading

Over the years we have had the privilege of seeing people diagnosed with malignant mesothelioma in different stages of their journey. Malignant mesothelioma is a rare cancer that is difficult to diagnose and to treat. Treatment options are limited and long term quality survival is the goal with ultimately leading to a cure. Always recommended has been getting treatment at a Mesothelioma Center of Excellence and participating in clinical trials. Treatment and research has been ongoing, but [...]

Continue reading

For the first time in 16 years, the U.S. Food & Drug Administration has approved a new drug combination specifically for the treatment of malignant pleural mesothelioma. The two drugs, which are to be used together when surgery is not an option, are Opdivo (nivolumab) and Yervoy (ipilimumab). About 20,000 Americans are diagnosed with malignant pleural mesothelioma each year according to the FDA – the vast majority of which have tumors at diagnosis that cannot be removed by surgery. The [...]

Continue reading

Download Your Free Mesothelioma Handbook & Treatment Guide

Free Mesothelioma Patient

& Treatment Guide

We’d like to offer you our in-depth guide, “A Patient’s Guide to Mesothelioma,” absolutely free of charge.

It contains a wealth of information and resources to help you better understand the condition, choose (and afford) appropriate treatment, and exercise your legal right to compensation.

HONcode Certified

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Office Location

Copyright MesotheliomaHelp.org
The information provided by Mesothelioma Help is not a substitute for professional medical advice, diagnosis or treatment.
Our website does not host any form of advertisement.

Mesothelioma Help Cancer Organization is sponsored by Belluck & Fox, LLP